Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-24 @ 7:22 PM
NCT ID:
NCT04863703
Eligibility Criteria:
Inclusion Criteria:
* Chronic HBV/HDV Coinfection
* suspected or diagnosed liver cirrhosis, indication for hepatovenous pressure gradient (HVPG) measurement or liver cirrhosis and HVPG measurement conducted in the past 12 months (conducted prior to antiviral treatment)
* indication for antiviral treatment with Bulevirtide
* age \>18years
* Must be willing to participate in the study and provide written informed consent
Exclusion Criteria:
* patient rejects study participation
* no conducted or no indication for HVPG measurement
* age \<18years
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04863703
Study Brief:
Protocol Section:
NCT04863703